The new Trump administration could put a stop to pending litigation on the abortion pill mifepristone and other federal abortion policies through changes at the Department of Health and Human Services, according to a top anti-abortion lawyer involved in several pending cases.
Erin Morrow Hawley, senior counsel for the religious legal advocacy firm Alliance Defending Freedom, told the Washington Examiner in an exclusive interview that she is hopeful that Robert F. Kennedy Jr., President Donald Trump’s nominee for HHS secretary, will swiftly resume the anti-abortion policies of Trump’s first term.
Undoing some of the Biden administration’s actions with respect to the controversial abortion pill mifepristone would end the litigation between anti-abortion advocates and the federal government.
Trending: Watch: Jennifer Aniston Has Opened Up on Barack Obama Cheating Rumor
“I think RFK Jr. has been clear in meetings
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!